Optimize day-to-day operations with cost-saving insights from leaders in office supplies, logistics, and travel. Hear from ODP and Corporate Traveler on how to stretch your budget while supporting ...

Join us for BIO Savings Week, a five-day virtual event series designed to help member companies unlock the full value of their membership. Each day spotlights several BIO Business Solutions® partners, ...

Intellectual property is at the center of U.S. biotech leadership. It plays an essential role in the development of lifesaving scientific advances - and the safeguarding of America's national security ...

Download past BIO Industry Analysis reports, and sign up to be notified of upcoming reports.

BIO filed an amicus brief July 19 in the case of Bristol Meyers Squibb and Janssen, who are appealing a decision by the U.S. District Court for the District of New Jersey. The companies argue that the ...

The Guide to Raising Institutional Private Capital is a comprehensive course designed to teach biotech CEOs and CFOs of companies that have already raised a Series A and are preparing for a Series B ...

Dear Colleagues, This month marks my one-year anniversary as BIO's CEO. Like most of us in biotech, this post has been a labor of love. At no time in my 25-year career in this industry have I ever ...

“Most favored nation is a deeply flawed proposal that would devastate our nation’s small- and mid-size biotech companies – the very companies that are the leading drivers of medical innovation in the ...

The ORPHAN Cures Act reaffirms Congress’s strong, bipartisan commitment to protect the research and development of new treatments for patients with rare diseases ...

BIO launches a new campaign to explain why we vaccinate – and why it's good for America. We have details, plus how drug companies are investing in U.S. manufacturing, news on drug prices and IP, and ...

At its simplest, biotechnology is technology based on biology - biotechnology harnesses cellular and biomolecular processes to develop technologies and products that help improve our lives and the ...

John Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement regarding the resignation of Peter Marks from the FDA: “Under the extraordinary ...